文献速递儿童口腔牙体牙髓病

羟基磷灰石防龋临床证据:更新系统综述与荟萃分析

Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis.
PubMed 文献 · J Dent · 2024-10-28

本更新系统综述与荟萃分析纳入18项研究,其中5项临床试验和8项原位试验进入荟萃分析,评估含羟基磷灰石口腔护理产品减少龋齿的效果。结论认为,无氟羟基磷灰石产品防龋证据有所扩展,更多研究表明羟基磷灰石在不含氟时是有效的抗龋活性成分。

要点

  • 含羟基磷灰石的无氟口腔护理产品防龋证据有所扩展。
  • 羟基磷灰石在不含氟条件下显示为有效的抗龋活性成分。
  • 羟基磷灰石可安全吞咽,适合作为幼儿牙膏和漱口水的氟替代物。

核心结论

  • 无氟含羟基磷灰石口腔护理产品减少龋齿的证据在随机对照试验和原位临床试验中均有扩展。
  • 更多研究表明羟基磷灰石在不含氟时是有效的抗龋活性成分。

研究设计与样本

  • 采用PICO框架检索PubMed、Scopus、EMBASE和Web of Science数据库。
  • 共检索到18项研究,最终5项临床试验和8项原位试验纳入荟萃分析。
  • 研究按美国国立卫生研究院分级系统进行分级,荟萃分析使用R统计程序完成。

主要发现

  • 18项检索研究中,5项临床试验和8项原位试验纳入荟萃分析。
  • 含羟基磷灰石口腔护理产品在无氟条件下显示减少龋齿的效果。

临床怎么用

  • 羟基磷灰石作为唯一活性成分可安全吞咽,适合作为幼儿牙膏和漱口水中氟的替代物。
  • 本综述新数据表明含羟基磷灰石口腔护理产品可用于所有年龄段人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: A systematic review and meta-analysis were undertaken to update our 3-year-old meta-analysis to include RCTs, in vivo, and in situ clinical evidence that showed hydroxyapatite in oral care products can reduce dental caries. DATA: Using the PICO guide, published clinical trials were searched where subjects (P) of all ages, with primary, mixed or permanent dentitions, using toothpastes, mouthwashes or gels containing hydroxyapatite as an active ingredient (I) were compared to subjects who used placebo or no intervention, or fluoride-containing positive controls (C), and the outcomes (O) were direct measurement of reduced dental caries or suitable proxy for reduced caries risk. SOURCES: PubMed, Scopus, EMBASE, and Web of Science databases were searched using search terms from previous searches. STUDY SELECTION: All authors collectively agreed which studies to include after applying the exclusion/inclusion criteria. Eighteen studies were retrieved and analyzed. The studies were graded according to a National Institutes of Health grading system. Three authors decided on the final list of publications suitable for meta-analysis, and the meta-analysis was carried out using the public domain R statistical program. RESULTS: After applying more specific inclusion criteria and assessment, out of 18 retrieved studies, 5 clinical trials and 8 in situ trials were included in the meta-analysis. CONCLUSIONS: The evidence for the effectiveness of fluoride-free, hydroxyapatite-containing oral care products in reducing dental caries, both from RCTs and in situ clinical trials, has expanded. More studies now show that hydroxyapatite is effective as an anti-caries active ingredient in the absence of fluoride. CLINICAL SIGNIFICANCE: As a sole active ingredient, considered safe if swallowed, hydroxyapatite is an ideal substitute for fluoride in toothpaste and mouthwash tailored for young children, and new data as presented in this review, demonstrated that hydroxyapatite-based oral care products can be used by people of all ages.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Pawinska M, Paszynska E, Amaechi BT, et al. Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. J Dent. 2024. PMID: 39471896. doi:10.1016/j.jdent.2024.105429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。